Navigation Links
AssureRx Adds VP of Sales and Marketing
Date:4/28/2008

Personalized medicine company prepares for commercial launch of first

product

CINCINNATI, April 28 /PRNewswire/ -- AssureRx, a personalized medicine company, announced that Al Lucas has joined the Company as vice president of sales and marketing. He will be responsible for developing the marketing plan and initial launch strategy, building the sales force, and leading the commercial introduction of the Company's first product. Lucas is an experienced pharmaceutical sales and marketing leader with more than 20 years of experience at companies such as Novartis, Pharmacia, and The Upjohn Company. In his various roles with those companies, he has participated in more than 15 successful product launches, including the highly successful Zyvox (linezolid). Additionally, he played roles in the planning, hiring and training of multiple sales forces.

"I was very excited about the opportunity to join AssureRx in this early stage," said Lucas. "The personalized medicine movement will change the way medicine is practiced, and AssureRx has positioned itself to become the market leader within the largest potential segment, the neuropsychiatric field. The Company has solid relationships with the thought leaders in psychopharmacogenetic research, which supports the development of our products. We will leverage this cutting-edge technology to bring tools to the marketplace which will help physicians provide individualized and highly-specific care to each patient," Lucas continued. "These are the hallmarks of personalized medicine."

Mark Byrne, AssureRx CEO added, "We are extremely pleased that Al has joined AssureRx. He brings a demonstrated track record of successful new product introductions and is experienced in the neuro-pscyh market segment. The addition of Al will accelerate our commercial introduction."

About AssureRx

AssureRx, LLC, is a personalized medicine company dedicated to helping physicians de
'/>"/>

SOURCE AssureRx, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AssureRx Closes Round of Funding to Commercialize Pharmacogenetic Test
2. Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company
3. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
4. Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
5. VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales
6. Developing Sales Leaders: Benchmarks Reveal Tactics that Will Propel Your Business
7. Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
8. Dilon Technologies Closes First Quarter With Record Sales
9. Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
10. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
11. Spectros Corporation Reports 2007 Year-Over-Year Sales Rise 36%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Two champions ... continued their sponsorship of an annual competition for middle ... and access to, innovative STEM study. The competition presents ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
(Date:1/15/2014)... 2013 was a banner year of continued innovation ... continued independent research led by the team at Wake ... million grant from the Susanne Marcus Collins Foundation, had ... reviewed journal, Amy Grant highlighted Brainwave Optimization® in First ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... February 28, Evotec AG (Frankfurt Stock Exchange: EVT) ... study for EVT 302 in smoking,cessation, a reversible ... This double-blind, three-way cross-over study is designed ... and withdrawal symptoms,after short-term deprivation of cigarettes in ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today ... Options in Healthcare Conference on Tuesday,March 4, 2008 at ... being,held at the W Hotel in New York., ... Anadys,Pharmaceuticals, Inc., will present an overview of Anadys and ...
... time, researchers at North Carolina State University have ... physically or chemically different so-called Janus particles ... alternating electrical field is applied to liquid surrounding ... published in the Feb. 8, 2008, edition of ...
Cached Biology Technology:Evotec Starts Phase II in Smoking Cessation with EVT 302 2Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference 2'2-faced' particles act like tiny submarines 2
(Date:7/9/2014)... derived from the oils produced by algae may offer ... this goal, optimization of cost effective strategies for large-scale ... needed. Sapphire Energy has developed an innovative solution to ... systems, described in Industrial Biotechnology , a peer-reviewed ... is available on the Industrial Biotechnology ...
(Date:7/9/2014)... about the prevalence of antibiotic-resistant illness, Case Western ... to disabling disease: blocking bacteria,s access to iron ... bacterial siderophore, a small molecule, captures iron from ... as well as how the body launches ... findings appear in a recent edition of ...
(Date:7/9/2014)... usually announce themselves with pain and fever but often can ... that are sneaky and hard to beat. Now, scientists have ... of tiny DNA pyramids. Published in the journal ACS ... can flag bacteria and kill more of them than medicine ... some infectious pathogens can lie in wait, undetectable in the ...
Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Bacteria hijack plentiful iron supply source to flourish 2
... genes significantly affect variation in voter turnout, shedding new ... in the political system. The research, conducted by ... UC San Diego) and psychologist Laura A. Baker (of ... of the American Political Science Review , a ...
... from research groups around Australia, the report includes chapters ... focus on steps that can be taken to adjust ... to the Farm Writers Association of NSW in Sydney ... Howden, said it was time for agriculture to start ...
... through a tropical or temperate forest immediately impresses us ... plant world, but our knowledge of how plants are ... Now, with data emerging from many genome sequencing projects, ... architecture at the molecular level. This knowledge has ...
Cached Biology News:Why do people vote? Genetic variation in political participation 2How to build a plant 2How to build a plant 3
... the needs of the biopharmaceutical ... supports fast cell growth rates ... maintaining high cell viability and ... the Baculovirus Expression Vector System ...
Mol wt: average mol wt12,360.96 Da by calculation...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
Biology Products: